Oncology & Cancer

FDA clears biomarker test for ovarian cancer

Approval last week by U.S. Food and Drug Administration (FDA) clears the path for nationwide use of tools that show the greatest specificity in estimating the risk of ovarian cancer in women with a pelvic mass.

Health

Old tobacco playbook gets new use by e-cigarettes

Companies vying for a stake in the fast-growing electronic cigarette business are reviving the decades-old marketing tactics the tobacco industry used to hook generations of Americans on regular smokes.

Dentistry

DIY dentistry—It's a don't

As direct-to-consumer marketing becomes pervasive, there's a growing trend of Do-It-Yourself or DIY dentistry—prompting patients to skip the trip to the orthodontist in favor of at-home impression kits and the ability to ...

Medications

UnitedHealth bulks up for prescription drug cost battle

The nation's largest health insurer, UnitedHealth, will muscle up for its fight against rising prescription drug costs by spending more than $12 billion to buy pharmacy benefits manager Catamaran Corp.

Medications

British drugs firm GSK settles US drug disputes for $3.0 bln

GlaxoSmithKline said on Thursday it had agreed to pay $3.0 billion (2.2 billion euros) to settle long-running disputes with the US government over how the British pharmaceuticals group marketed and developed drugs.

page 2 from 14